Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04420949 · ClinicalTrials.gov registry record · NA

Sensory Training for Visual Motion Sickness

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT04420949: Completed NA study, sponsored by University of Wisconsin, Madison.

NCT04420949 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04420949, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

This is a preliminary study to determine the reliability and validity of new tests of orientation and balance, as well as to test the effects of a new treatment for visually induced dizziness. Tests involve determining vertical alignment. The treatment is task-based and involves focusing attention on internal body sensations to help improve the sense of upright. Testing is done twice before and twice after treatment, which is provided twice-weekly during a three-week period between testing. The total time participants are involved in the study is approximately six weeks.

Primary Outcome

An image of a rod will be shown in the central portion of the visual field. The surrounding virtual environment will be void. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without any reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position

Interventions

  • BEHAVIORAL Sensory re-weighting

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-03-19
Est. Completion 2021-06-30
Phase NA
University of Wisconsin, Madison

1,039 total trials

What the finished NCT04420949 record still lists

NCT04420949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Sensory re-weighting is the first listed.

NCT04420949 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04420949 about?

NCT04420949 is a clinical study titled "Sensory Training for Visual Motion Sickness". This is a preliminary study to determine the reliability and validity of new tests of orientation and balance, as well as to test the effects of a new treatment for visually induced dizziness. Tests involve determining vertical alignment. The treatment is task-based and involves focusing attention o...

What is the current status of trial NCT04420949?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-03-19. Estimated completion is 2021-06-30.

What interventions are being tested in trial NCT04420949?

The interventions under investigation include: Sensory re-weighting (BEHAVIORAL).

Who is sponsoring clinical trial NCT04420949?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04420949's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04420949, the US trial registry maintained by the National Library of Medicine. NCT04420949 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.